GH
HZNP

GAM Holding’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

GAM Holding’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,056
Closed -$1.28M – 198
2023
Q3 		$1.28M Sell
11,056
-1,848
-14% -$199K 0.09% 145
2023
Q2 		$1.33M Sell
12,904
-4,300
-25% -$454K 0.09% 156
2023
Q1 		$1.88M Buy
17,204
+7,500
+77% +$829K 0.13% 151
2022
Q4 		$1.1M Buy
+9,704
New +$806K 0.09% 164
2019
Q4 		– Sell
-13,842
Closed -$377K – 864
2019
Q3 		$377K Sell
13,842
-1,160
-8% -$30K 0.02% 666
2019
Q2 		$361K Buy
15,002
+4,290
+40% +$109K 0.01% 743
2019
Q1 		$283K Buy
+10,712
New +$254K 0.01% 751
2018
Q3 		– Sell
-14,115
Closed -$234K – 1002
2018
Q2 		$234K Buy
+14,115
New +$215K 0.01% 842

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GAM Holding's HZNP Position: Q4 2023 in Review

GAM Holding sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 11,056 shares — an estimated $1.28M sold.

GAM Holding first reported a position in HZNP in Q2 2018 and held it in 8 quarters. The position peaked at $1.88M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • GAM Holding reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • GAM Holding sold 11,056 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.28M.
  • GAM Holding first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2018 and held it in 8 quarters.
  • GAM Holding's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.88M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on GAM Holding's 13F filing for Q4 2023, filed 23 Jan 2024.